Clinical Trials
32 trialsStudy of Kidney Tumors in Younger Patients
Children's Oncology Group
S0931
SWOG Cancer Research Network
3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
Canadian Cancer Trials Group
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
Canadian Cancer Trials Group
Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
Eastern Cooperative Oncology Group
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Eastern Cooperative Oncology Group
Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
Eastern Cooperative Oncology Group
Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer
Eastern Cooperative Oncology Group
Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Eastern Cooperative Oncology Group
Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
Children's Oncology Group
Effects of Anesthesia on Immunity in Cancer
Meshalkin Research Institute of Pathology of Circulation
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Children's Oncology Group
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Children's Oncology Group
Biomarkers in Urine Samples From Patients With Wilms Tumor
Children's Oncology Group
DNA Variations in the Gene in Young Patients With Wilms' Tumor
Children's Oncology Group
Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor
Children's Oncology Group
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors
Children's Oncology Group
Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
Children's Oncology Group
Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
Children's Oncology Group
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
Children's Oncology Group
SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer
SWOG Cancer Research Network
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Children's Oncology Group
Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC
S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
SWOG Cancer Research Network
Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC
NGR-TNF in Treating Patients With Advanced Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC